Ralph Niven - Net Worth and Insider Trading
Ralph Niven Net Worth
The estimated net worth of Ralph Niven is at least $33,065 dollars as of 2024-05-17. Ralph Niven is the CHIEF SCIENTIFIC OFFICER of Aerovate Therapeutics Inc and owns about 1,609 shares of Aerovate Therapeutics Inc (AVTE) stock worth over $33,065. Details can be seen in Ralph Niven's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ralph Niven has not made any transactions after 2024-02-05 and currently still holds the listed stock(s).
Transaction Summary of Ralph Niven
Ralph Niven Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ralph Niven owns 2 companies in total, including Windtree Therapeutics Inc (WINT) , and Aerovate Therapeutics Inc (AVTE) .
Click here to see the complete history of Ralph Niven’s form 4 insider trades.
Insider Ownership Summary of Ralph Niven
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| WINT | Windtree Therapeutics Inc | 2004-05-11 | Sr. VP Preclinical Development |
| AVTE | Aerovate Therapeutics Inc | 2024-02-05 | Chief Development Officer |
Ralph Niven Latest Holdings Summary
Ralph Niven currently owns a total of 1 stock. Ralph Niven owns 1,609 shares of Aerovate Therapeutics Inc (AVTE) as of February 5, 2024, with a value of $33,065.
Latest Holdings of Ralph Niven
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTE | Aerovate Therapeutics Inc | 2024-02-05 | 1,609 | 20.55 | 33,065 |
Holding Weightings of Ralph Niven
Ralph Niven Form 4 Trading Tracker
According to the SEC Form 4 filings, Ralph Niven has made a total of 16 transactions in Aerovate Therapeutics Inc (AVTE) over the past 5 years, including 0 buys and 16 sells. The most-recent trade in Aerovate Therapeutics Inc is the sale of 4,600 shares on February 5, 2024, which brought Ralph Niven around $80,270.
Insider Trading History of Ralph Niven
- 1
Ralph Niven Trading Performance
Ralph Niven Ownership Network
Ralph Niven Owned Company Details
What does Windtree Therapeutics Inc do?
Who are the key executives at Windtree Therapeutics Inc?
Ralph Niven is the Sr. VP Preclinical Development of Windtree Therapeutics Inc. Other key executives at Windtree Therapeutics Inc include director & Chief Executive Officer Craig Fraser , VP & Controller & & CAO Jamie Mcandrew , and SVP & CFO John P. Hamill .
Windtree Therapeutics Inc (WINT) Insider Trades Summary
Over the past 18 months, Ralph Niven made no insider transaction in Windtree Therapeutics Inc (WINT). Other recent insider transactions involving Windtree Therapeutics Inc (WINT) include a net purchase of 7,812 shares made by Craig Fraser ,
In summary, during the past 3 months, insiders sold 0 shares of Windtree Therapeutics Inc (WINT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Windtree Therapeutics Inc (WINT) were sold and 434 shares were bought by its insiders, resulting in a net purchase of 434 shares.
Windtree Therapeutics Inc (WINT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Windtree Therapeutics Inc Insider Transactions
Ralph Niven Mailing Address
Above is the net worth, insider trading, and ownership report for Ralph Niven. You might contact Ralph Niven via mailing address: C/o Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
